Sotalol
File:Sotalol.svg | |
Systematic (IUPAC) name | |
---|---|
(RS)-N-{4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl}methanesulfonamide | |
Clinical data | |
Pregnancy category |
|
Routes of administration | oral |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | >95% |
Metabolism | Not metabolized[citation needed] |
Biological half-life | 12 hours |
Excretion |
Renal Lactic (In lactating females) |
Identifiers | |
CAS Number | 3930-20-9 |
ATC code | C07AA07 (WHO) |
PubChem | CID 5253 |
DrugBank | DB00489 |
Chemical data | |
Formula | C12H20N2O3S |
Molar mass | 272.3624 g/mol[[Script error: No such module "String".]] |
(verify) |
Sotalol (trade names Betapace and Betapace AF, Berlex Laboratories, Sotalex and Sotacor, Bristol-Myers Squibb) is a drug used in individuals with rhythm disturbances (cardiac arrhythmias) of the heart, and to treat hypertension in some individuals.
Sotalol is a non-selective beta blocker. It is also a potassium channel blocker and is therefore a class III anti-arrhythmic agent. Because of this dual-action, Sotalol prolongs both the PR interval and the QT interval.
Indications
Sotalol is used to treat ventricular tachycardias[1] as well as atrial fibrillation.[2] Betapace AF is specifically labeled for atrial fibrillation.
Some evidence suggests that sotalol should be avoided in the setting of decreased ejection fraction due to an increased risk of death.[3]
It has also been suggested that it be used in the prevention of atrial fibrillation.[4]
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
es:Sotalol hr:Sotalol it:Sotalolo hu:Szotalol nl:Sotalol pl:Sotalol pt:Sotalol ru:Соталол fi:Sotaloli
sv:Sotalol- ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
- ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
- ↑ Waldo A, Camm A, deRuyter H, Friedman P, MacNeil D, Pauls J, Pitt B, Pratt C, Schwartz P, Veltri E (1996). "Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol". Lancet. 348 (9019): 7–12. doi:10.1016/S0140-6736(96)02149-6. PMID 8691967.
- ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
- Pages with script errors
- Pages with broken file links
- Drugs with non-standard legal status
- All articles with unsourced statements
- Articles with unsourced statements from May 2010
- Articles with invalid date parameter in template
- Infobox drug articles with non-default infobox title
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- 2Fix
- Antiarrhythmic agents
- Beta blockers
- Sulfonamides
- Potassium channel blockers
- Alcohols
- Cardiovascular system drug stubs
- CS1 maint: Multiple names: authors list